Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ivax Laboratories Inc.

Division of Teva Pharmaceutical Industries Ltd.
www.ivaxlaboratories.com

Latest From Ivax Laboratories Inc.

Smoking Cessation Label Changes Could Lay Groundwork For Indications

FDA drops its requirement for labeling provisions for NRTs on duration of use and concomitant use of tobacco or other NRTs. Meanwhile, the agency rejects citizen petition requests for additional NRT indications, but says it is open to working with sponsors on developing those indications.

Consumer United States

Smoking Cessation Label Changes Could Lay Groundwork For Indications

FDA drops its requirement for labeling provisions for NRTs on duration of use and concomitant use of tobacco or other NRTs. Meanwhile, the agency rejects citizen petition requests for additional NRT indications, but says it is open to working with sponsors on developing those indications.

Consumer United States
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Wakefield Pharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Teva Pharmaceutical Industries Ltd.
  • Senior Management
  • Derek Kish, Dir., Marketing
    Jesus Leal, Pres.
  • Contact Info
  • Ivax Laboratories Inc.
    Phone: (770) 664-1661
    310 Maxwell Rd.
    Ste. 100
    Alpharetta, GA 30004
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register